spacer
spacer

PDBsum entry 1kjc

Go to PDB code: 
protein links
Cell adhesion protein PDB id
1kjc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
106 a.a.
Theoretical model
PDB id:
1kjc
Name: Cell adhesion protein
Title: Theoretical model of the human cd6 ligand alcam (activated leukocyte-cell adhesion molecule), n-terminal receptor-binding domain
Structure: Cd6 ligand alcam. Chain: null. Fragment: n-terminal immunoglobulin-like domain. Synonym: activated leukocyte-cell adhesion molecule
Source: Homo sapiens. Human
Authors: J.Bajorath,M.A.Bowen,A.Aruffo
Key ref:
J.Bajorath et al. (1995). Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM. Protein Sci, 4, 1644-1647. PubMed id: 8520490 DOI: 10.1002/pro.5560040822
Date:
28-Nov-95     Release date:   03-Apr-96    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Struc: 106 a.a.
Key:    Secondary structure

 

 
DOI no: 10.1002/pro.5560040822 Protein Sci 4:1644-1647 (1995)
PubMed id: 8520490  
 
 
Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.
J.Bajorath, M.A.Bowen, A.Aruffo.
 
  ABSTRACT  
 
CD6-ligand interactions have been implicated in the regulation of T-cell adhesion and activation. CD6 is a member of the scavenger receptor family, whereas its human ligand (ALCAM) belongs to the immunoglobulin superfamily. The extracellular region of ALCAM includes five immunoglobulin-like domains. As a fusion protein, the N-terminal extracellular domain of ALCAM (ALCAMD1) binds specifically to CD6. We report the construction, assessment, and analysis of a molecular model of ALCAMD1. The model defines the CDR-analogous loops, the location of N-linked glycosylation sites, and residues that form the beta-sheet faces of the immunoglobulin-like domain. Predicted structural characteristics of the A'GFCC'C" face of the model are consistent with the presence of monomeric and dimeric forms of ALCAMD1, which has implications for the receptor-ligand interactions.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Structure-orientedsequencealignmet of ALCAMDI(ALC) andCD8.The /3-strands of CD8andthecorresponding(predicted) ALCAMDIP-strandsareunderlined(theA-strandinCD8,predicted to be absent in ALCAMDl, is notshown).Residuenumbersare forALCAMDl The predicted CDR-analogous regions in ALCAMDIare annotated,and IgSF V-set residues are labeled (*). ALCAMDI loopregionsmodeled by conforationalserchare given in lowercase. Residuesidentical CD8andALCAMDlandthe mostconservative replacementsareshowninbold.
Figure 2.
Fig. 2. tereorepresentationof theALCAMDl A ALCAMDl monomer,backboneshown as a solid ribbon. The termini (N, C),the faces A'GFCC'C, green; BED, blue), andthe CDR-analogous loops (1-4, yellow) are labeled. Positionsofpotential N-linked glycosylation sites are colored in magenta. B Possible Fv-like homodier monomers col- ored in ray and pink, ALCAMDlatthetopand thegraymonoer at thebottom have thesameorientation. The spatialarrangementofcomplementary negatively charged (red), positively charged (blue), and hydrophobic (gold) resi- duesthought tobe consistent with Fv-like dimerization (as discussed in he text) can be seen. Modeling methods: For computer graphics, model building, and energy minimizations, the InsightWDiscover package (version 2.3.0.; Biosym Technologies, San was used. Loop conformations were modeled by conformational search using COGEN (version ) (Bruccoleri & Novotny, 1992). For each loop,theconformation minimum solvent-accessible surface within 3 kcal/mol of the energy min- imum conformation was selected. Side-chain conformations of surface residues were modeled using low-energy side-chain rota- mers (Ponder & Richards, 1987). Conservative side-chain replacements in core regions were modeled in conformations as similar as possible tothe originl residue. The initially assembled model was subjected to someminor minimization (until the RMS ofthe energy function was - 1.5 kcal/mol/A) to relieve stereochemical constraints.This resulted in a cumula- tive proteinbackbone RMS deviation (of th &strands to thestructuraltemplate)of less than .5 A.
 
  The above figures are reprinted from an Open Access publication published by the Protein Society: Protein Sci (1995, 4, 1644-1647) copyright 1995.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
10861932 M.A.Bowen, A.A.Aruffo, and J.Bajorath (2000).
Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
  Proteins, 40, 420-428.  
9556065 S.P.Bruder, N.S.Ricalton, R.E.Boynton, T.J.Connolly, N.Jaiswal, J.Zaia, and F.P.Barry (1998).
Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation.
  J Bone Miner Res, 13, 655-663.  
  9260290 J.E.Skonier, M.A.Bowen, A.Aruffo, and J.Bajorath (1997).
CD6 recognizes the neural adhesion molecule BEN.
  Protein Sci, 6, 1768-1770.  
9209500 M.A.Bowen, J.Bajorath, M.D'Egidio, G.S.Whitney, D.Palmer, J.Kobarg, G.C.Starling, A.W.Siadak, and A.Aruffo (1997).
Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
  Eur J Immunol, 27, 1469-1478.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer